GLAUKOS Corp 4

SVP & CFO Alex R. Thurman exercised 10,000 Glaukos (GKOS) stock options at $38.68 and sold 10,000 common shares at $160.00 under a Rule 10b5-1 plan on July 16, 2026.

On July 16, 2026, Glaukos Corporation SVP & Chief Financial Officer Alex R. Thurman exercised 10,000 stock options at $38.68 per share and immediately sold 10,000 shares of common stock at $160.00 per share under a pre-established Rule 10b5-1 trading plan, effectively monetizing the option spread while keeping his net share count unchanged from the exercise/sale pair. Following these transactions, he directly owned 43,906 shares of common stock, including 5,230 unvested restricted stock units and 225 shares acquired via the employee stock purchase plan, with his post-transaction equity stake worth approximately $6.7 million at the current market price. The option exercise was reported as a routine compensation-related transaction, and the sale was clearly identified as being conducted under a 10b5-1 plan adopted on December 15, 2025.

Filing Facts

CIK

1192448

Ticker

GKOS

Form

4

Source Type

fda

Accession

0001920061-26-000016

Alert Tier

6